The Epoch Times
The Epoch Times
AD
The Epoch Times
Support Us
Policies & Impacts

27 Drugs Will Be Cheaper for Medicare Recipients From April

27 Drugs Will Be Cheaper for Medicare Recipients From April
Xavier Becerra, secretary of Health and Human Services (HHS), speaks during a press conference at the HHS headquarters in Washington, on June 28, 2022. Nicholas Kamm/AFP via Getty Images
Naveen Athrappully
Naveen Athrappully
3/16/2023|Updated: 3/16/2023
0:00

Some beneficiaries of Medicare could start paying less for 27 prescription drugs from next month as their prices have exceeded the rate of inflation.

“Today, the Department of Health and Human Services [HHS], through the Centers for Medicare & Medicaid Services (CMS), announced 27 prescription drugs for which Part B beneficiary coinsurances may be lower from April 1—June 30, 2023,” said a March 15 CMS press release. “Some people with Medicare who take these drugs may save between $2 and $390 per average dose starting April 1, depending on their individual coverage.”

Naveen Athrappully
Naveen Athrappully
Author
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Author’s Selected Articles

Arkansas Can Enforce Critical Race Theory Ban in Classrooms, Appeals Court Rules

Jul 17, 2025
Arkansas Can Enforce Critical Race Theory Ban in Classrooms, Appeals Court Rules

Columbia University Announces Commitment to Combating Anti-Semitism

Jul 17, 2025
Columbia University Announces Commitment to Combating Anti-Semitism

European Energy Giants Sign Deals to Buy American LNG

Jul 17, 2025
European Energy Giants Sign Deals to Buy American LNG

Trump Administration Strengthens Work-From-Home Options for Federal Employees for Religious Reasons

Jul 17, 2025
Trump Administration Strengthens Work-From-Home Options for Federal Employees for Religious Reasons
Related Topics
Medicare
prescription drugs
drug pricing
Inflation Reduction Act of 2022
medicare drugs
Save
The Epoch Times
To ensure we reach the high standards of reliability and neutrality that you expect from us, we are engaging with Ad Fontes Media to analyze our content. If you find an article you think falls short of the standard, please submit the link through this form.
Copyright © 2000 - 2025 The Epoch Times Association Inc. All Rights Reserved.